Metastatic Prostate Cancer in US Continues Its Upward Trend
Rising incidence rates of metastatic prostate cancer in the US coincide temporally with USPSTF recommendations against routine PSA-based prostate cancer screening.
Rising incidence rates of metastatic prostate cancer in the US coincide temporally with USPSTF recommendations against routine PSA-based prostate cancer screening.
Medicare is a significant insurer for patients seeking urologic surgeries.
Percutaneous ablation for small renal masses is associated with a higher retreatment rate compared with partial nephrectomy, according to a study.
There is no universal approach to patient selection for cytoreductive nephrectomy.
Study finds lower mortality rates associated with excisions of higher numbers of lymph nodes in patients with intermediate- and high-risk prostate cancer.
In a study, no patient was diagnosed with high-grade prostate cancer within 3 years following a negative prostate MRI and negative systematic prostate biopsy.
Concomitant anti-androgen therapy may ameliorate the worse outcomes associated with delayed salvage radiation therapy for recurrent prostate cancer after radical surgery.
Segmental ureterectomy is increasingly adopted for high-risk upper tract urothelial carcinoma.
A recent study characterized disease recurrence patterns and predictive risk factors for recurrence in patients who underwent radical nephroureterectomy for low-grade upper tract urothelial carcinoma.
Among men with Medicare coverage, Hispanic men had a significant 37% decreased risk for death compared with both non-Hispanic White men and Black men, a study found.